Tubilux Pharma develops, manufactures and markets a line of prescription and non-prescription products to treat a wide range of eye disorders, including glaucoma, ocular inflammation, infection and dry eye. The Company has core competencies in three business areas: the development and commercialization of the Tubilux brand eye care pharmaceuticals in Europe and selected international markets; pharmaceutical contract manufacturing and value added services for major and emerging pharmaceutical companies; research and development support activities. The company has special expertise in the manufacture of ointments, gels and eye drops in multi dose and lyophilized formats and in the development of new products, screening of new formulations, validations, pilot plant and scale-up services. Its key market is Italy. The Company has a dedicated marketing group and a professional, full-time employed medical sales force.